New diabetes clinical trial: A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-3" and "BR1019-2" in Healthy Volunteers

Published on: October 10, 2024 at 11:00PM
Conditions: Essential Hypertension; Type 2 Diabetes
Interventions: Drug: BR1019; Drug: BR1019-2; Drug: BR1019-3
Sponsors: Boryung Pharmaceutical Co., Ltd
Not yet recruiting
https://ift.tt/IdonMa5